Indapamide microhemodynamic effects in patients with essential arterial hypertension

The aim of this study was to investigate microcirculatory (M) changes and andothelin-1 levels in 3-month indapamide treatment. The study included 22patients with essential arterial hypertension (EAH), Stage I-II, and 12 normotensive controls. Microcirculation was assessed by laser Dopplerflowmetry,...

Full description

Saved in:
Bibliographic Details
Main Authors: L. N. Eliseeva, Z. A. Baste, S. P. Oransky, A. Yu. Blednova, Z. A. Avakimyan
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2005-06-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/2440
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The aim of this study was to investigate microcirculatory (M) changes and andothelin-1 levels in 3-month indapamide treatment. The study included 22patients with essential arterial hypertension (EAH), Stage I-II, and 12 normotensive controls. Microcirculation was assessed by laser Dopplerflowmetry, endothelin-1 level - by enzyme immunoassay method. The EAH patients demonstrated M heterogeneity, with high prevalence of pathologic M types. Indapamide was effective and safe in EAH treatment, improving M status. Serum levels of endothelin-1 correlated with Doppler flowmetric indices - Aa/IM, alpha-rhythm amplitude, as well as with blood pressure levels.
ISSN:1560-4071
2618-7620